Group 1 - The stock price of Shutaishen closed at 53.00 yuan on August 27, 2025, down by 3.70 yuan, representing a decline of 6.53% from the previous trading day [1] - The trading volume on that day was 341,939 hands, with a transaction amount of 1.875 billion yuan [1] - Shutaishen operates in the biopharmaceutical sector, focusing on the research and development of innovative drugs, primarily for treating neurological and immune system diseases [1] Group 2 - According to the company's semi-annual report for 2025, it achieved operating revenue of 126 million yuan in the first half of the year, a year-on-year decrease of 31.14% [1] - The net loss attributable to the parent company was 25 million yuan [1] - On August 27, the net outflow of main funds for Shutaishen was 345 million yuan, with a cumulative net outflow of 741 million yuan over the past five days [1]
舒泰神股价下跌6.53% 公司回应股东人数披露问题